Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts. When the lame-duck Congress returns to Washington after Election Day, it will face a long list of health items needing attention before the end of the year, […]
Category: Capitol Desk
KHN’s ‘What the Health?’: Graham’s Bill Recenters Abortion Debate
Republicans would like to shift the political focus away from abortion to economic issues for the midterm elections, but a bill from Sen. Lindsey Graham (R-S.C.) that would ban most abortions after 15 weeks of pregnancy has put the issue squarely back on their agenda. The proposal was not welcomed by many of his colleagues, especially Minority Leader Mitch McConnell. Also this week, the muddle about where the fight against covid stands and near-record-low numbers of uninsured in the U.S. Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Margot Sanger-Katz of The New York Times join KHN’s partnerships editor, Mary Agnes Carey, to discuss these issues and more.
KHN’s ‘What the Health?’: A Big Week for Biden
Congress is leaving for its annual summer break having accomplished far more than many expected, including, barring unforeseen snags, a bill to address the cost of prescription drugs for Medicare beneficiaries and extend the enhanced subsidies for insurance premiums under the Affordable Care Act. Meanwhile, the abortion issue continues to roil the nation as Indiana becomes the first state to ban the procedure in almost all cases since the Supreme Court overruled the constitutional right to abortion in June. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare
Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.
Clinics Say California’s New Medicaid Drug Program Will Force Them to Cut Services
On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.
KHN’s ‘What the Health?’: Boosting Confusion
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.